Background Image
Table of Contents Table of Contents
Previous Page  28 / 492 Next Page
Information
Show Menu
Previous Page 28 / 492 Next Page
Page Background

15:56 - 15:59

S2-8

(PP)

KCNG4: A NOVEL GENE CANDIDATE UNDERLYING VESICOURETERAL REFLUX

Abhishek SETH, In-Seon CHOI, Chester KOH, Patricio GARGOLLO, David ROTH, Carolina JORGEZ and Dolores LAMB

Baylor College of Medicine, Scott Department of Urology, Houston, USA

PURPOSE

A genetic basis for VUR has been inferred through linkage analysis studies, yet few candidate genes are known. Using

comparative genomic hybridization microarray analysis (aCGH), we identified KCNG4 as a novel candidate gene

underlying vesicoureteral reflux. KCNG4 encodes a protein that functions as a modulatory unit in a voltage gated

potassium channel. We hypothesize that gene dosage changes in the KCNG4 gene are responsible for VUR in a subset of

children.

MATERIAL AND METHODS

Genomic DNA from 35 pediatric patients with VUR and 5 control patients was analyzed by aCGH using 720K NimbleGen

arrays (Roche). Quantitative PCR was performed using CNV-taqman assays to validate putative regions of duplication

or deletion that were distinct from CNVs found throughout the genome.

RESULTS

We identified a microdeletion of 74,043 base pairs spanning a single gene - KCNG4 (16q24.1). This deletion in KCNG4

was validated using qPCR. This deletion was outside areas of known benign copy number variations (CNVs) and was not

present in healthy, disease-free controls. Incidence of known defects in KCNG4 in the population of individuals tested

for a variety of indications is 0.04%, as extracted from the DECIPHER database. We identified two patients in the

DECIPHER database with duplications in KCNG4 and concomitant GU tract anomalies including VUR and

hypospadias. We conducted in-situ hybridization and found robust KCNG4 expression in the developing GU tract of

mouse embryos. Initial phenotypic analysis of the first Kcng4 -/- mouse showed bilateral VUR.

CONCLUSIONS

We used aCGH analysis to identify KCNG4 as a possible novel gene defect that may be responsible for VUR in a subset

of patients. Recapitulation of VUR in KCNG4 knockout mouse models would prove causation beyond association. Using

CRISPR genome editing, we have produced Kcng4 knockout mice and are in the process of conducting phenotypic

analyses.